论文部分内容阅读
糖尿病慢性并发症主要是血管病变 ,糖尿病肾病 (ＤＮ )和糖尿病眼病 (ＤＲ )均属糖尿病微血管病变。导升明 (Ｄｏｘｉｕｍ ,ｃａｌｃｉｕｍｄｏｂｅｓｉｌａｔｅ)为目前公认的预防和治疗ＤＲ的较理想的药物[1] 。常用于ＤＲ的治疗 ,但对其他微血管病变的治疗作用尚未见报道。本
Chronic complications of diabetes are mainly vascular disease, diabetic nephropathy (DN) and diabetic eye disease (DR) are diabetic microangiopathy. Doxium (Doxium, calciumdobesilate) is currently recognized as the ideal drug for the prevention and treatment of DR [1]. Commonly used in the treatment of DR, but the treatment of other microangiopathic effects have not been reported. this